Finance

Lists
1LNTH:BIT
Lantheus Holdings Inc
€87.10
-1.69%
(-1.50) 1D
Sep 30, 10:25:37 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1LNTH...
Mkt. cap
6.54B
Avg. vol.
2.00
Volume
0.00
52-wk high
€107.20
52-wk low
€43.37
No. of employees
1K
Mkt. cap
6.54B
Avg. vol.
2.00
Volume
0.00
52-wk high
€107.20
52-wk low
€43.37
No. of employees
1K
News stories
From web sources and news partners
Profile
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
About Lantheus Holdings Inc
CEO-
Employees1.19K
Founded1956
HeadquartersNorth Billerica, Massachusetts, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
384.01M
406.79M
377.33M
388.18M
Cost of goods sold
161.65M
165.91M
146.41M
146.32M
Cost of revenue
161.65M
165.91M
146.41M
146.32M
Research and development expenses
48.02M
47.48M
39.38M
38.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
130.73M
115.81M
109.86M
103.44M
Operating expense
178.75M
163.29M
149.24M
141.64M
Total operating expenses
340.40M
329.20M
295.65M
287.96M
Operating income
43.62M
77.58M
81.68M
100.22M
Other non operating income
-798.00K
-9.00K
-462.00K
2.51M
EBT including unusual items
42.38M
70.36M
156.40M
93.82M
EBT excluding unusual items
41.22M
75.25M
82.53M
103.16M
Income tax expense
14.61M
16.28M
37.99M
18.80M
Effective tax rate
34.47%
23.13%
24.29%
20.03%
Other operating expenses
-
-
-
-
Net income
27.77M
54.09M
118.42M
75.03M
Net profit margin
7.23%
13.30%
31.38%
19.33%
Earnings per share
1.27
1.67
1.46
1.55
Interest and investment income
3.62M
3.07M
4.97M
6.26M
Interest expense
-4.95M
-5.08M
-4.86M
-4.92M
Net interest expenses
-1.33M
-2.00M
105.00K
1.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
64.02M
100.41M
104.37M
122.80M
Gain or loss from assets sale
-
-5.00M
-59.33M
-199.00K
AI content may include mistakes. Learn more
Google apps